Not available
Quote | Simulations Plus Inc. (NASDAQ:SLP)
Last: | $46.86 |
---|---|
Change Percent: | -0.24% |
Open: | $46.29 |
Close: | $46.86 |
High: | $47.91 |
Low: | $45.8901 |
Volume: | 261,616 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
News | Simulations Plus Inc. (NASDAQ:SLP)
2024-07-02 19:28:10 ET Simulations Plus, Inc. (SLP) Q3 2024 Earnings Conference Call July 02, 2024, 05:00 PM ET Company Participants Lisa Fortuna - Investor Relations, Financial Profiles Shawn O'Connor - Chief Executive Officer Will Frederick - Chief Financial Of...
2024-07-02 16:07:16 ET More on Simulations Plus Simulations Plus: Reliance On Consulting And Acquisitions Creates Doubts Simulations Plus, Inc. 2024 Q2 - Results - Earnings Call Presentation Simulations Plus, Inc. (SLP) Q2 2024 Earnings Call Transcript Simula...
Message Board Posts | Simulations Plus Inc. (NASDAQ:SLP)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $SLP News Article - Simulations Plus and the University of Florida Awarded New FDA Cont | whytestocks | investorshangout | 11/02/2022 6:30:59 PM |
whytestocks: $SLP News Article - Simulations Plus Hosts 2nd Annual Pharmacometrics Workshop | whytestocks | investorshangout | 06/30/2022 3:00:51 PM |
You are a fu..ni genius with $SLP, but | swampboots | investorshub | 12/27/2020 3:30:35 PM |
I just noticed that you have the honor | dickmilde | investorshub | 12/27/2020 12:29:06 PM |
whytestocks: $SLP News Article - Simulations Plus to Participate in the Credit Suisse Virtual Health | whytestocks | investorshangout | 11/05/2020 7:55:53 PM |
News, Short Squeeze, Breakout and More Instantly...
Total revenue of $18.5 million and diluted earnings per share (EPS) of $0.15 Maintains full-year revenue guidance of $69 to $72 million and updates EPS guidance Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulati...
2024-06-24 16:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications for the biopharma industry, today announced that Shawn O’Connor, chief executive officer, will...